gleevec Pill - orange capsule/oblong, 19mm
Generic Name: imatinib
Pill with imprint gleevec is Orange, Capsule/Oblong and has been identified as Gleevec 400 mg. It is supplied by Novartis Pharmaceuticals Corporation.
Gleevec is used in the treatment of Chronic Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Dermatofibrosarcoma Protuberans; Chronic Eosinophilic Leukemia; Gastrointestinal Stromal Tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Gleevec 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for gleevec
Gleevec
- Generic Name
- imatinib
- Imprint
- gleevec
- Strength
- 400 mg
- Color
- Orange
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals Corporation
- National Drug Code (NDC)
- 00078-0649
- Inactive Ingredients
-
silicon dioxide,
crospovidone,
ferric oxide red,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol 4000,
magnesium silicate,
hypromelloses,
ferric oxide yellow,
water
Note: Inactive ingredients may vary.
More about Gleevec (imatinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (37)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.